Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREMFYA in Breast Milk of Lactating Women
NCT07654751Phase 4Recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 4 trial of guselkumab in psoriasis, ulcerative colitis (UC), Crohn's disease, psoriatic arthritis (PsA), sponsored by Janssen Pharmaceutical. Started Aug 2026; status: recruiting.
02
Drugs
guselkumab
03
Conditions
psoriasisulcerative colitis (UC)Crohn's diseasepsoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT07654751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07654751.